HomeFinanceConformis, Inc. (CFMS) Stock Trending Up Following 510(k) Clearance from FDA for...

Conformis, Inc. (CFMS) Stock Trending Up Following 510(k) Clearance from FDA for Identity Imprint

Conformis, Inc. (CFMS) stock prices were up 5.9061% during the first half of the trading day on May 10th, 2021, bringing the price per share up to USD$0.8912.

510(k) Clearance for Conformis

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


May 10th, 2021 saw CFMS announce that the U.S. Food and Drug Administration had granted 510(k) clearance to the company’s Identity Imprint Knee Replacement System. The innovative total knee replacement system is available in both the cruciate retaining (CR) and posterior stabilized (PS) versions, thereby expanding the range of options available to Conformis’ orthopedic surgeon customers and their patients.

Synergetic Product Offering

While the Conformis iTotal Identity knee replacement system is tailored to precisely fit each patient’s unique anatomy, Identity imprint combines pre-determined implant sizes with standard and patient-specific surgical instrumentation. Identity Imprint facilitates faster delivery times for surgeons, as well as intraoperative options that are more similar to standard knee systems.

Identity Imprint

Identity Imprint matches patients’ computed tomography scans with the implant that is geometrically and anatomically closest to those requirements, using a proprietary 3-D best-fit algorithm. Ambulatory surgical centers (ASCs) can expect greater procedural efficiency and reduced sterilization costs over standard systems as a result of Conformis’ sterile “surgery-in-box” system, which is the conduit for the delivery of Identity Imprint.

Benefits of Identity Imprint

As the newest addition to the company’s product portfolio, Identity Imprint has seen the leveraging of the company’s technological resources and data from tens of thousands of personalized implant designs. This facilitates intraoperative flexibility and faster product availability for surgeons. The standard six weeks lead time for the iTotal Identity fully personalized system is cut in half for the Identity Imprint system to be able to provide a patient match.

Scope of Market

While primarily meeting the needs of the ASC care setting, invaluable in-patient hospital care during the pandemic environment will also be facilitated. With the global knee joint reconstruction market projected to be greater than USD$9 billion, with 1 million knee replacements expected to be performed in the U.S. alone over the course of 2021, CFMS seems to be on the verge of potential exponential growth.

Future Outlook for CFMS

With the strength of its consolidated product portfolio that sets it apart from its competitors, CFMS is poised to leverage the resources at its disposal to facilitate further future growth. Current and potential investors are hopeful the company will be able to continue to expand the size and scope of its footprint within the market sector.


Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Related News


Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free



Download Free eBook For


100% free. stop anytime no spam